IOL to diversify its API and specialty chemicals portfolios to boost sales

The Ludhiana-based company generates about 30% of its ₹2,216 crore revenues from the commodity API ibuprofen, where it is vertically integrated manufacturing the key starting material Isobutylbenzene needed for making the drug. Ibuprofen, an age-old drug, is used in the treatment of pain.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EFRNVP4
via IFTTT